A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating The Efficacy And Safety Of Empasiprubart Versus Intravenous Immunoglobulin In Adults With Multifocal Motor Neuropathy
Posted Date: Sep 10, 2025
- Investigator: Hani Kushlaf
- Specialties: Neurology, Neuromuscular Disorders
- Type of Study: Drug
The study aims to compare empasiprubart and IVIg for treating participants with MMN. It will look at how the study drug affects MMN disease outcomes, like muscle function and strength, and the ability to grasp and move objects. It will also look at how the study drug affects the participant’s quality of life.
Criteria:
Participants Must Have A Confirmed Diagnosis Of Definite Or Probable Mmn. 18 Years Or Older. Has Responded To Ivig In The Past 5 Years.
Keywords:
Multifocal Motor Neuropathy, Mmn
For More Information:
Sara Reiber
5135582968
searss2@ucmail.uc.edu